Evidence map›Paper›PMID 31045746›Full record

SynthesisPain2019

Quantitative sensory testing and predicting outcomes for musculoskeletal pain, disability, and negative affect: a systematic review and meta-analysis.

Vasileios Georgopoulos, Kehinde Akin-Akinyosoye, Weiya Zhang, Daniel F McWilliams, Paul Hendrick, David A Walsh

2 registry-linked trialsOpen access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Pain, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 117 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
117citing papers in PubMed, 6 pooled it
17.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04902196 nacompletednot on this mapstarted 2021, after this paper: background citation

Acute Effects of a High Intensity Training Protocol on Pain Processing and Inflammatory Parameters in Persons With Chronic Nonspecific Low Back Pain.

TypeinterventionalSponsorHasselt UniversityRan2021 to 2022Enrolled40ConditionsLow Back Pain, InflammationArmshigh intensity cardiorespiratory exercise protocol, moderate intensity cardiorespiratory exercise protocol
NCT06544291 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Combination of THC and CBD as Novel Treatment for Co-Occurring Opioid Use Disorder and Chronic Pain

TypeinterventionalSponsorYale UniversityRan2024 to 2028Enrolled147ConditionsChronic Pain, Opioid Use DisorderArmsCBD 300mg, CBD 600mg, Placebo 0mg
3 · Its place in the literature

Who cites it

117 citing papers in PubMed, 6 syntheses or guidelines pooled it, 218 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Observational

57 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vasileios GeorgopoulosDepartment of Academic Rheumatology, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.
Kehinde Akin-AkinyosoyeDepartment of Academic Rheumatology, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.
Weiya ZhangDepartment of Academic Rheumatology, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.
Daniel F McWilliamsDepartment of Academic Rheumatology, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.
Paul HendrickArthritis Research UK Pain Centre, University of Nottingham, Nottingham, United Kingdom.
David A WalshDepartment of Academic Rheumatology, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom.
Versus Arthritis · GBUniversity of Nottingham · GB

Funding

Versus Arthritis 20777
6 · The paper itself

Abstract

Hypersensitivity due to central pain mechanisms can influence recovery and lead to worse clinical outcomes, but the ability of quantitative sensory testing (QST), an index of sensitisation, to predict outcomes in chronic musculoskeletal disorders remains unclear. We systematically reviewed the evidence for ability of QST to predict pain, disability, and negative affect using searches of CENTRAL, MEDLINE, EMBASE, AMED, CINAHL, and PubMed databases up to April 2018. Title screening, data extraction, and methodological quality assessments were performed independently by 2 reviewers. Associations were reported between baseline QST and outcomes using adjusted (β) and unadjusted (r) correlations. Of the 37 eligible studies (n = 3860 participants), 32 were prospective cohort studies and 5 randomised controlled trials. Pain was an outcome in 30 studies, disability in 11, and negative affect in 3. Meta-analysis revealed that baseline QST predicted musculoskeletal pain (mean r = 0.31, 95% confidence interval [CI]: 0.23-0.38, n = 1057 participants) and disability (mean r = 0.30, 95% CI: 0.19-0.40, n = 290 participants). Baseline modalities quantifying central mechanisms such as temporal summation and conditioned pain modulation were associated with follow-up pain (temporal summation: mean r = 0.37, 95% CI: 0.17-0.54; conditioned pain modulation: mean r = 0.36, 95% CI: 0.20-0.50), whereas baseline mechanical threshold modalities were predictive of follow-up disability (mean r = 0.25, 95% CI: 0.03-0.45). Quantitative sensory testing indices of pain hypersensitivity might help develop targeted interventions aiming to improve outcomes across a range of musculoskeletal conditions.

Indexed as

AffectHumansMusculoskeletal PainPain MeasurementPain ThresholdPersons with DisabilitiesPrognosisProspective StudiesRandomized Controlled Trials as Topic

Identifiers

PMID31045746
PMCPMC6701980
OpenAlexW2942868138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.